0001209191-12-028588.txt : 20120516
0001209191-12-028588.hdr.sgml : 20120516
20120516163248
ACCESSION NUMBER: 0001209191-12-028588
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120509
FILED AS OF DATE: 20120516
DATE AS OF CHANGE: 20120516
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 12849200
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0305
4
2012-05-09
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST
CAMBRIDGE
MA
02139
0
1
0
0
SVP & Corp Controller
Common Stock
2012-05-09
4
M
0
7500
36.27
A
13625
D
Common Stock
2012-05-09
4
M
0
7032
18.93
A
20657
D
Common Stock
2012-05-09
4
M
0
5156
33.28
A
25813
D
Common Stock
2012-05-09
4
M
0
3515
32.16
A
29328
D
Common Stock
2012-05-09
4
M
0
1125
37.86
A
30453
D
Common Stock
2012-05-09
4
M
0
8437
39.05
A
38890
D
Common Stock
2012-05-09
4
M
0
4687
38.80
A
43577
D
Common Stock
2012-05-09
4
M
0
3281
33.82
A
46858
D
Common Stock
2012-05-09
4
M
0
12187
33.55
A
59045
D
Common Stock
2012-05-09
4
M
0
3375
51.75
A
62420
D
Common Stock
2012-05-09
4
S
0
55295
60.85
D
7125
D
Common Stock
2012-05-09
4
S
0
1000
61.08
D
6125
D
Common Stock
1380
I
401(k)
Stock Option
36.27
2012-05-09
4
M
0
7500
0.00
D
2007-11-13
2017-08-12
Common Stock
7500
0
D
Stock Option
18.93
2012-05-09
4
M
0
7032
0.00
D
2008-05-07
2018-02-06
Common Stock
7032
0
D
Stock Option
33.28
2012-05-09
4
M
0
5156
0.00
D
2009-10-16
2019-07-15
Common Stock
5156
2344
D
Stock Option
32.16
2012-05-09
4
M
0
3515
0.00
D
2008-10-24
2018-07-23
Common Stock
3515
235
D
Stock Option
37.86
2012-05-09
4
M
0
1125
0.00
D
2012-05-02
2022-02-01
Common Stock
1125
16875
D
Stock Option
39.05
2012-05-09
4
M
0
8437
0.00
D
2010-05-04
2020-02-03
Common Stock
8437
6563
D
Stock Option
38.80
2012-05-09
4
M
0
4687
0.00
D
2011-05-03
2021-02-02
Common Stock
4687
10313
D
Stock Option
33.82
2012-05-09
4
M
0
3281
0.00
D
2010-10-14
2020-07-13
Common Stock
3281
4219
D
Stock Option
33.55
2012-05-09
4
M
0
12187
0.00
D
2009-05-05
2019-02-04
Common Stock
12187
2813
D
Stock Option
51.75
2012-05-09
4
M
0
3375
0.00
D
2011-10-13
2021-07-12
Common Stock
3375
14625
D
Open market sales reported on this line occurred at a weighted average price of $60.85 (range $60.85 to $60.95).
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $61.08 (range $61.02 to $61.09).
David T. Howton, Attorney-In-Fact
2012-05-16